Vital health programmes and research are brought to a halt in Uganda, a major beneficiary of US overseas aid funding.

Malaria vaccination and HIV treatment are among numerous health programmes at risk in Uganda as the country's science research centres suffer the impact of a US freeze on overseas aid.

“In addition to these, PEPFAR has been supporting 16,690 community health workers and lay workers. These have been deployed across 2,000 health facilities in Uganda. Some of the ...

The unstaffed reception area at the Kampala offices of Uganda Young Positives (UYP ... a clinic receives funding through the U.S. program PEPFAR, this preventative medication can "only" be ...

PEPFAR helped turn the tide against HIV/AIDS in Africa, leading to declining infection rates and rising life expectancy in countries like Tanzania, Uganda, and Zambia. Now, those hard-won gains ...

or PEPFAR. Those funds were part of the $5 billion PEFPAR had invested in HIV prevention and treatment services in Uganda by 2023, the program’s 20th anniversary. Now Regina Kamoga is worried ...

KAMPALA, Uganda — A prominent opposition figure jailed in Uganda for allegedly threatening state security is unwell and in need of urgent medical care, his attorney said Thursday. Four-time ...

The President's Emergency Plan for AIDS Relief received a waiver from the Trump administration's initial stop-work order for ...

The President's Emergency Plan for AIDS Relief has been the subject of a series of presidential orders and memos that have ...